Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aderbasib with Trastuzumab and Vinorelbine in HER2+ Breast Cancer
NCT01254136Phase 2Terminated
- Sponsor
- Incyte
- Start
- Oct 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of aderbasib in HER2-positive breast cancer, sponsored by Incyte. Primary endpoint: Evaluation of safety and tolerability. Started Oct 2010; status: terminated.
02
Drugs
aderbasib
03
Conditions
HER2-positive breast cancer
Beyond the preview
Go deeper on NCT01254136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01254136.